Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart

Author:

Lorenz Kristina1234ORCID,Rosner Marsha Rich5,Brand Theresa34,Schmitt Joachim P67

Affiliation:

1. Comprehensive Heart Failure Center; University of Würzburg; Versbacher Straße 9 97078 Würzburg Germany

2. West German Heart and Vascular Center Essen; University Hospital Essen; Hufelandstraße 55 45147 Essen Germany

3. Leibniz-Institut für Analytische Wissenschaften - ISAS - e.V.; Bunsen-Kirchhoff-Straße 11 44139 Dortmund Germany

4. Institute of Pharmacology and Toxicology; University of Würzburg; Versbacher Straße 9 97078 Würzburg Germany

5. Ben May Department for Cancer Research; University of Chicago; Chicago IL 60637 USA

6. Institute of Pharmacology and Clinical Pharmacology; Düsseldorf University Hospital; Universtitätsstraße 1 40225 Düsseldorf Germany

7. Cardiovascular Research Institute Düsseldorf (CARID); Heinrich-Heine-University; Universtitätsstraße 1 40225 Düsseldorf Germany

Funder

Bundesministerium für Bildung und Forschung

Deutsche Forschungsgemeinschaft

Ministry for Innovation, Science and Research of the Federal State of North Rhine-Westphalia

Publisher

Wiley

Subject

Physiology

Reference119 articles.

1. Cardioprotective and survival benefits of long-term combined therapy with β2 adrenoreceptor (AR) agonist and β1AR blocker in dilated cardiomyopathy postmyocardial infarction;Ahmet;J Pharmacol Exp Ther,2008

2. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins;Alves;Circ Cardiovasc Genet,2014

3. Myocardial infarction in mice alters sarcomeric function via post-translational protein modification;Avner;Mol Cell Biochem,2011

4. Adrenergic signaling in heart failure: a balance of toxic and protective effects;Baker;Pflugers Arch,2014

5. Beta3-adrenoreceptors in cardiovasular diseases: new roles for an "old" receptor;Balligand;Curr Drug Deliv,2013

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3